In breast and gall bladder cancer, patients with high Ep-CAM-expressing primary tumours indeed showed a decreased survival (Gastl et al, 2000; Spizzo et al, 2002; Spizzo et al, 2004; Varga et al, 2004). Here, EPCAM is linked to neoplasm.